金斯瑞致力于为全球科研机构提供新冠病毒(SARS-CoV-2, COVID-19)研究级多肽。
针对热门靶点，金斯瑞专家团队参考现有文献，以丰富的经验设计了多种新冠病毒相关多肽为您全方位提供支持，您可以根据需求选择 多肽合成、 多肽文库*、或 肽池等交付形式，用于免疫学等研究。
更多信息，请联系金斯瑞专业技术支持团队 peptide@genscript.com.cn。
如需定制化多肽文库合成服务， 点击此处在线提交需求。
| 产品编号 | 多肽名称 | 蛋白种类 | 对应蛋白全序列 | 规格 | 纯度 | 价格 | 周期 | 订购 |
|---|---|---|---|---|---|---|---|---|
| RP30223CN | SARS-CoV-2 Spike Glycoprotein BA.5-Omicron | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
粗肽 | ¥4,900 | 现货 | 立即订购 |
| RP30221CN | SARS-CoV-2 Spike Glycoprotein BA.2-Omicron | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
粗肽 | ¥4,900 | 现货 | 立即订购 |
| RP30219CN | SARS-CoV-2 Spike Glycoprotein-Omicron-90% purity | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
90% | ￥6,860 | 现货 | 立即订购 |
| P30121CN | SARS-CoV-2 Spike Glycoprotein B.1.1.529-Omicron | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
粗肽 | ￥4,900 | 现货 | 立即订购 |
| RP30034CN | SARS-CoV-2 Spike Glycoprotein RBD B.1.617.2-Delta | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoproteinSARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 1 vial (25µg/peptide) |
粗肽 | ￥1,500 | 现货 | 立即订购 |
| RP30033CN | SARS-CoV-2 Spike Glycoprotein B.1.617.2-Delta | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
粗肽 | ￥4,900 | 现货 | 立即订购 |
| RP30025CN | SARS-CoV-2 Spike Glycoprotein B.1.1.7-Alpha | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
粗肽 | ￥4,900 | 现货 | 立即订购 |
| RP30026CN | SARS-CoV-2 Spike Glycoprotein RBD B.1.1.7-Alpha | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,500 | 现货 | 立即订购 |
| RP30027CN | SARS-CoV-2 Spike Glycoprotein-90% | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25µg/peptide) |
90% | ￥6,860 | 现货 | 立即订购 |
| RP30010CN | HCoV-229E Spike Glycoprotein | Human coronavirus 229E (HCoV-229E) Spike glycoprotein | Sequence | 2 vials (25 µg/peptide) |
粗肽 | ¥4,900 | 现货 | 立即订购 |
| RP30011CN | HCoV-OC43 Spike glycoprotein | Human coronavirus OC43 (HCoV-OC43) Spike glycoprotein | Sequence | 2 vials (25 µg/peptide) |
粗肽 | ¥4,900 | 现货 | 立即订购 |
| RP30012CN | SARS-CoV-2 ORF3a | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Protein 3a | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,500 | 现货 | 立即订购 |
| RP30013CN | SARS-CoV-2 N | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Nucleoprotein | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,920 | 现货 | 立即订购 |
| RP30014CN | SARS-CoV-2 ORF6 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Non-structural protein 6 | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30015CN | SARS-CoV-2 ORF7b | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Non-structural Protein 7b | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30016CN | SARS-CoV-2 ORF7a | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Non-structural protein 7A | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30017CN | SARS-CoV-2 ORF8 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Non-structural protein 8 | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30018CN | SARS-CoV-2 ORF10 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) ORF10 Protein | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30019CN | SARS-CoV-2 ORF9B | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Protein 9b | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30020CN | SARS-CoV-2 Spike Glycoprotein | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | Sequence | 2 vials (25 µg/peptide) |
粗肽 | ¥4,900 | 现货 | 立即订购 |
| RP30021CN | SARS-CoV-2 E | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Envelope small membrane protein | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
| RP30022CN | SARS-CoV-2 M | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Membrane protein | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,500 | 现货 | 立即订购 |
| RP30023CN | SARS-CoV-2 Y14 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Uncharacterized protein 14 | Sequence | 1 vial (25µg/peptide) |
粗肽 | ¥1,050 | 现货 | 立即订购 |
更多多肽详情，请参考 MolecularCloud-多肽。
| 多肽名称 | 靶点类型 | 相关蛋白ID | 多肽序列 | 纯度 | 订购 | |
|---|---|---|---|---|---|---|
| 单字母形式 | 三字母形式 | |||||
| SARS-CoV-2 Nucleoprotein, 138-146 | Nucleoprotein | P0DTC9 | ALNTPKDHI | {ALA}{LEU}{ASN}{THR}{PRO}{LYS}{ASP}{HIS}{ILE} |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 |
| SARS-CoV-2 Nucleoprotein, 159-167 | Nucleoprotein | P0DTC9 | LQLPQGTTL | {LEU}{GLN}{LEU}{PRO}{GLN}{GLY}{THR}{THR}{LEU} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 219-227 | Nucleoprotein | P0DTC9 | LALLLLDRL | {LEU}{ALA}{LEU}{LEU}{LEU}{LEU}{ASP}{ARG}{LEU} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 222-230 | Nucleoprotein | P0DTC9 | LLLDRLNQL | {LEU}{LEU}{LEU}{ASP}{ARG}{LEU}{ASN}{GLN}{LEU} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 292-308 | Nucleoprotein | P0DTC9 | IRQGTDYKHWPQIAQFA | {ILE}{ARG}{GLN}{GLY}{THR}{ASP}{TYR}{LYS}{HIS}{TRP}{PRO}{GLN}{ILE}{ALA}{GLN}{PHE}{ALA} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 299-315 | Nucleoprotein | P0DTC9 | KHWPQIAQFAPSASAFF | {LYS}{HIS}{TRP}{PRO}{GLN}{ILE}{ALA}{GLN}{PHE}{ALA}{PRO}{SER}{ALA}{SER}{ALA}{PHE}{PHE} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 305-322 | Nucleoprotein | P0DTC9 | AQFAPSASAFFGMSRIGM | {ALA}{GLN}{PHE}{ALA}{PRO}{SER}{ALA}{SER}{ALA}{PHE}{PHE}{GLY}{MET}{SER}{ARG}{ILE}{GLY}{MET} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 305-319 | Nucleoprotein | P0DTC9 | AQFAPSASAFFGMSR | {ALA}{GLN}{PHE}{ALA}{PRO}{SER}{ALA}{SER}{ALA}{PHE}{PHE}{GLY}{MET}{SER}{ARG} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 313-330 | Nucleoprotein | P0DTC9 | AFFGMSRIGMEVTPSGTW | {ALA}{PHE}{PHE}{GLY}{MET}{SER}{ARG}{ILE}{GLY}{MET}{GLU}{VAL}{THR}{PRO}{SER}{GLY}{THR}{TRP} |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 |
| SARS-CoV-2 Nucleoprotein, 316-324 | Nucleoprotein | P0DTC9 | GMSRIGMEV | {GLY}{MET}{SER}{ARG}{ILE}{GLY}{MET}{GLU}{VAL} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 322-331 | Nucleoprotein | P0DTC9 | MEVTPSGTWL | {MET}{GLU}{VAL}{THR}{PRO}{SER}{GLY}{THR}{TRP}{LEU} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 351-359 | Nucleoprotein | P0DTC9 | ILLNKHIDA | {ILE}{LEU}{LEU}{ASN}{LYS}{HIS}{ILE}{ASP}{ALA} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 351-358 | Nucleoprotein | P0DTC9 | ILLNKHID | {ILE}{LEU}{LEU}{ASN}{LYS}{HIS}{ILE}{ASP} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 352-369 | Nucleoprotein | P0DTC9 | LLNKHIDAYKTFPPTEPK | {LEU}{LEU}{ASN}{LYS}{HIS}{ILE}{ASP}{ALA}{TYR}{LYS}{THR}{PHE}{PRO}{PRO}{THR}{GLU}{PRO}{LYS} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 360-375 | Nucleoprotein | P0DTC9 | YKTFPPTEPKKDKKKK | {TYR}{LYS}{THR}{PHE}{PRO}{PRO}{THR}{GLU}{PRO}{LYS}{LYS}{ASP}{LYS}{LYS}{LYS}{LYS} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 40-54 | Nucleoprotein | P0DTC9 | RRPQGLPNNTASWFT | {ARG}{ARG}{PRO}{GLN}{GLY}{LEU}{PRO}{ASN}{ASN}{THR}{ALA}{SER}{TRP}{PHE}{THR} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 226-234 | Nucleoprotein | P0DTC9 | RLNQLESKM | {ARG}{LEU}{ASN}{GLN}{LEU}{GLU}{SER}{LYS}{MET} |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 |
| SARS-CoV-2 Nucleoprotein, 260-274 | Nucleoprotein | P0DTC9 | QKRTATKAYNVTQAF | {GLN}{LYS}{ARG}{THR}{ALA}{THR}{LYS}{ALA}{TYR}{ASN}{VAL}{THR}{GLN}{ALA}{PHE} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 265-274 | Nucleoprotein | P0DTC9 | TKAYNVTQAF | {THR}{LYS}{ALA}{TYR}{ASN}{VAL}{THR}{GLN}{ALA}{PHE} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 320-334 | Nucleoprotein | P0DTC9 | IGMEVTPSGTWLTYT | {ILE}{GLY}{MET}{GLU}{VAL}{THR}{PRO}{SER}{GLY}{THR}{TRP}{LEU}{THR}{TYR}{THR} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 325-339 | Nucleoprotein | P0DTC9 | TPSGTWLTYTGAIKL | {THR}{PRO}{SER}{GLY}{THR}{TRP}{LEU}{THR}{TYR}{THR}{GLY}{ALA}{ILE}{LYS}{LEU} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 125-139 | Nucleoprotein | P0DTC9 | ANKDGIIWVATEGAL | {ALA}{ASN}{LYS}{ASP}{GLY}{ILE}{ILE}{TRP}{VAL}{ALA}{THR}{GLU}{GLY}{ALA}{LEU} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 215-229 | Nucleoprotein | P0DTC9 | GDAALALLLLDRLNQ | {GLY}{ASP}{ALA}{ALA}{LEU}{ALA}{LEU}{LEU}{LEU}{LEU}{ASP}{ARG}{LEU}{ASN}{GLN} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 329-346 | Nucleoprotein | P0DTC9 | TWLTYTGAIKLDDKDPNF | {THR}{TRP}{LEU}{THR}{TYR}{THR}{GLY}{ALA}{ILE}{LYS}{LEU}{ASP}{ASP}{LYS}{ASP}{PRO}{ASN}{PHE} | 立即订购 | |
| SARS-CoV-2 Nucleoprotein, 329-353 | Nucleoprotein | P0DTC9 | TWLTYTGAIKLDDKDPNFKDQVILL | {THR}{TRP}{LEU}{THR}{TYR}{THR}{GLY}{ALA}{ILE}{LYS}{LEU}{ASP}{ASP}{LYS}{ASP}{PRO}{ASN}{PHE}{LYS}{ASP}{GLN}{VAL}{ILE}{LEU}{LEU} |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 |
| SARS-CoV-2 Membrane protein, 61-70 | Membrane protein | P0DTC5 | TLACFVLAAV | {THR}{LEU}{ALA}{CYS}{PHE}{VAL}{LEU}{ALA}{ALA}{VAL} | 立即订购 | |
| SARS-CoV-2 Membrane protein, 89-97 | Membrane protein | P0DTC5 | GLMWLSYFI | {GLY}{LEU}{MET}{TRP}{LEU}{SER}{TYR}{PHE}{ILE} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 1011-1028 | Spike glycoprotein | P0DTC2 | QLIRAAEIRASANLAATK | {GLN}{LEU}{ILE}{ARG}{ALA}{ALA}{GLU}{ILE}{ARG}{ALA}{SER}{ALA}{ASN}{LEU}{ALA}{ALA}{THR}{LYS} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 1060-1068 | Spike glycoprotein | P0DTC2 | VVFLHVTYV | {VAL}{VAL}{PHE}{LEU}{HIS}{VAL}{THR}{TYR}{VAL} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 1185-1193 | Spike glycoprotein | P0DTC2 | RLNEVAKNL | {ARG}{LEU}{ASN}{GLU}{VAL}{ALA}{LYS}{ASN}{LEU} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 1192-1200 | Spike glycoprotein | P0DTC2 | NLNESLIDL | {ASN}{LEU}{ASN}{GLU}{SER}{LEU}{ILE}{ASP}{LEU} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 1220-1228 | Spike glycoprotein | P0DTC2 | FIAGLIAIV | {PHE}{ILE}{ALA}{GLY}{LEU}{ILE}{ALA}{ILE}{VAL} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 891-906 | Spike glycoprotein | P0DTC2 | GAALQIPFAMQMAYRF | {GLY}{ALA}{ALA}{LEU}{GLN}{ILE}{PRO}{PHE}{ALA}{MET}{GLN}{MET}{ALA}{TYR}{ARG}{PHE} |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 |
| SARS-CoV-2 Spike glycoprotein, 902-917 | Spike glycoprotein | P0DTC2 | MAYRFNGIGVTQNVLY | {MET}{ALA}{TYR}{ARG}{PHE}{ASN}{GLY}{ILE}{GLY}{VAL}{THR}{GLN}{ASN}{VAL}{LEU}{TYR} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 957-973 | Spike glycoprotein | P0DTC2 | QALNTLVKQLSSNFGAI | {GLN}{ALA}{LEU}{ASN}{THR}{LEU}{VAL}{LYS}{GLN}{LEU}{SER}{SER}{ASN}{PHE}{GLY}{ALA}{ILE} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 958-966 | Spike glycoprotein | P0DTC2 | ALNTLVKQL | {ALA}{LEU}{ASN}{THR}{LEU}{VAL}{LYS}{GLN}{LEU} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 976-984 | Spike glycoprotein | P0DTC2 | VLNDILSRL | {VAL}{LEU}{ASN}{ASP}{ILE}{LEU}{SER}{ARG}{LEU} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 996-1004 | Spike glycoprotein | P0DTC2 | LITGRLQSL | {LEU}{ILE}{THR}{GLY}{ARG}{LEU}{GLN}{SER}{LEU} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 424-433 | Spike glycoprotein | P0DTC2 | KLPDDFTGCV | {LYS}{LEU}{PRO}{ASP}{ASP}{PHE}{THR}{GLY}{CYS}{VAL} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 691-699 | Spike glycoprotein | P0DTC2 | SIIAYTMSL | {SER}{ILE}{ILE}{ALA}{TYR}{THR}{MET}{SER}{LEU} | 立即订购 | |
| SARS-CoV-2 Spike glycoprotein, 747-763 | Spike glycoprotein | P0DTC2 | TECSNLLLQYGSFCTQL | {THR}{GLU}{CYS}{SER}{ASN}{LEU}{LEU}{LEU}{GLN}{TYR}{GLY}{SER}{PHE}{CYS}{THR}{GLN}{LEU} |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 |
| SARS-CoV-2 Spike glycoprotein, 647-664 | Spike glycoprotein | P0DTC2 | AGCLIGAEHVNNSYECDI | {ALA}{GLY}{CYS}{LEU}{ILE}{GLY}{ALA}{GLU}{HIS}{VAL}{ASN}{ASN}{SER}{TYR}{GLU}{CYS}{ASP}{ILE} | 立即订购 | |
| (Biotin - Ahx) - SARS - CoV - 2 Spike RBM (receptor binding motif) | Biotin-Ahx-SNNLDSKVGGNYNYLYRLFRK | Biotin-Ahx-{Ser}{Asn}{Asn}{Leu}{Asp}{Ser}{Lys}{Val}{Gly}{Gly}{Asn}{Tyr}{Asn}{Tyr}{Leu}{Tyr}{Arg}{Leu}{Phe}{Arg}{Lys}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 | RVQPTESIVRFPNITNL | H-{Arg}{Val}{Gln}{Pro}{Thr}{Glu}{Ser}{Ile}{Val}{Arg}{Phe}{Pro}{Asn}{Ile}{Thr}{Asn}{Leu}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 - Lys(Biotin - Ahx) | RVQPTESIVRFPNITNL-K(Biotin-Ahx)-NH2 | H-{Arg}{Val}{Gln}{Pro}{Thr}{Glu}{Ser}{Ile}{Val}{Arg}{Phe}{Pro}{Asn}{Ile}{Thr}{Asn}{Leu}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 | CPFGEVFNATRF | H-{Cys}{Pro}{Phe}{Gly}{Glu}{Val}{Phe}{Asn}{Ala}{Thr}{Arg}{Phe}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 - Lys(Biotin - Ahx) | CPFGEVFNATRF-K(Biotin-Ahx)-NH2 | H-{Cys}{Pro}{Phe}{Gly}{Glu}{Val}{Phe}{Asn}{Ala}{Thr}{Arg}{Phe}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 | ASVYAWNRKR | H-{Ala}{Ser}{Val}{Tyr}{Ala}{Trp}{Asn}{Arg}{Lys}{Arg}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 - Lys(Biotin - Ahx) | ASVYAWNRKR-K(Biotin-Ahx)-NH2 | H-{Ala}{Ser}{Val}{Tyr}{Ala}{Trp}{Asn}{Arg}{Lys}{Arg}{Lys}(Biotin-Ahx)-NH2 |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 | ||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 | AWNRKRISNCVADY | H-{Ala}{Trp}{Asn}{Arg}{Lys}{Arg}{Ile}{Ser}{Asn}{Cys}{Val}{Ala}{Asp}{Tyr}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 - Lys(Biotin - Ahx) | AWNRKRISNCVADY-K(Biotin-Ahx)-NH2 | H-{Ala}{Trp}{Asn}{Arg}{Lys}{Arg}{Ile}{Ser}{Asn}{Cys}{Val}{Ala}{Asp}{Tyr}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 | SASFSTFKCYGVSPTKLNDLCFTN | H-{Ser}{Ala}{Ser}{Phe}{Ser}{Thr}{Phe}{Lys}{Cys}{Tyr}{Gly}{Val}{Ser}{Pro}{Thr}{Lys}{Leu}{Asn}{Asp}{Leu}{Cys}{Phe}{Thr}{Asn}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 - Lys(Biotin - Ahx) | SASFSTFKCYGVSPTKLNDLCFTN-K(Biotin-Ahx)-NH2 | H-{Ser}{Ala}{Ser}{Phe}{Ser}{Thr}{Phe}{Lys}{Cys}{Tyr}{Gly}{Val}{Ser}{Pro}{Thr}{Lys}{Leu}{Asn}{Asp}{Leu}{Cys}{Phe}{Thr}{Asn}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 | VYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT | H-{Val}{Tyr}{Ala}{Asp}{Ser}{Phe}{Val}{Ile}{Arg}{Gly}{Asp}{Glu}{Val}{Arg}{Gln}{Ile}{Ala}{Pro}{Gly}{Gln}{Thr}{Gly}{Lys}{Ile}{Ala}{Asp}{Tyr}{Asn}{Tyr}{Lys}{Leu}{Pro}{Asp}{Asp}{Phe}{Thr}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 - Lys(Biotin - Ahx) | VYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT-K(Biotin-Ahx)-NH2 | H-{Val}{Tyr}{Ala}{Asp}{Ser}{Phe}{Val}{Ile}{Arg}{Gly}{Asp}{Glu}{Val}{Arg}{Gln}{Ile}{Ala}{Pro}{Gly}{Gln}{Thr}{Gly}{Lys}{Ile}{Ala}{Asp}{Tyr}{Asn}{Tyr}{Lys}{Leu}{Pro}{Asp}{Asp}{Phe}{Thr}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 | LSFELLHA | H-{Leu}{Ser}{Phe}{Glu}{Leu}{Leu}{His}{Ala}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 - Lys(Biotin - Ahx) | LSFELLHA-K(Biotin - Ahx)-NH2 | H-{Leu}{Ser}{Phe}{Glu}{Leu}{Leu}{His}{Ala}{Lys}(Biotin-Ahx)-NH2 |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 | ||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 | TVCGPKKSTNLVKNKCVNF | H-{Thr}{Val}{Cys}{Gly}{Pro}{Lys}{Lys}{Ser}{Thr}{Asn}{Leu}{Val}{Lys}{Asn}{Lys}{Cys}{Val}{Asn}{Phe}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 - Lys(Biotin - Ahx) | TVCGPKKSTNLVKNKCVNF-K(Biotin - Ahx)-NH2 | H-{Thr}{Val}{Cys}{Gly}{Pro}{Lys}{Lys}{Ser}{Thr}{Asn}{Leu}{Val}{Lys}{Asn}{Lys}{Cys}{Val}{Asn}{Phe}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 | SNNLDSKVGGNYNYLYRLFRK | H-{Ser}{Asn}{Asn}{Leu}{Asp}{Ser}{Lys}{Val}{Gly}{Gly}{Asn}{Tyr}{Asn}{Tyr}{Leu}{Tyr}{Arg}{Leu}{Phe}{Arg}{Lys}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 | NYLYRLFRKSNLKPFERDISTEIY | H-{Asn}{Tyr}{Leu}{Tyr}{Arg}{Leu}{Phe}{Arg}{Lys}{Ser}{Asn}{Leu}{Lys}{Pro}{Phe}{Glu}{Arg}{Asp}{Ile}{Ser}{Thr}{Glu}{Ile}{Tyr}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - Lys(Biotin - Ahx) | NYLYRLFRKSNLKPFERDISTEIY-K(Biotin - Ahx)-NH2 | H-{Asn}{Tyr}{Leu}{Tyr}{Arg}{Leu}{Phe}{Arg}{Lys}{Ser}{Asn}{Leu}{Lys}{Pro}{Phe}{Glu}{Arg}{Asp}{Ile}{Ser}{Thr}{Glu}{Ile}{Tyr}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 | CNGVEGFNCYFPLQSYG | H-{Cys}{Asn}{Gly}{Val}{Glu}{Gly}{Phe}{Asn}{Cys}{Tyr}{Phe}{Pro}{Leu}{Gln}{Ser}{Tyr}{Gly}-OH |
粗品 ≥70% ≥75% ≥80% ≥85% ≥90% ≥95% ≥98% |
立即订购 | ||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - Lys(Biotin - Ahx) | CNGVEGFNCYFPLQSYG-K(Biotin - Ahx)-NH2 | H-{Cys}{Asn}{Gly}{Val}{Glu}{Gly}{Phe}{Asn}{Cys}{Tyr}{Phe}{Pro}{Leu}{Gln}{Ser}{Tyr}{Gly}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 | TNGVGYQPYR | H-{Thr}{Asn}{Gly}{Val}{Gly}{Tyr}{Gln}{Pro}{Tyr}{Arg}-OH | 立即订购 | |||
| SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - Lys(Biotin - Ahx) | TNGVGYQPYR-K(Biotin - Ahx)-NH2 | H-{Thr}{Asn}{Gly}{Val}{Gly}{Tyr}{Gln}{Pro}{Tyr}{Arg}{Lys}(Biotin-Ahx)-NH2 | 立即订购 | |||
| Angiotensin I Converting Enzyme 2, (ACE - 2) Substrate | Mca-APK(Dnp) | Mca-{Ala}{Pro}{Lys}(Dnp)-OH | 立即订购 | |||
| DX 600, ACE2 Inhibitor | Ac-GDYSHCSPLRYYPWWKCTYPDPEGGG-NH2 | Ac-{Gly}{Asp}{Tyr}{Ser}{His}{Cys}{Ser}{Pro}{Leu}{Arg}{Tyr}{Tyr}{Pro}{Trp}{Trp}{Lys}{Cys}{Thr}{Tyr}{Pro}{Asp}{Pro}{Glu}{Gly}{Gly}{Gly}-NH2 | 立即订购 | |||
***参考文献
1. Lee, Chloe Hyun-Jung, and Hashem Koohy. "In silico identification of
vaccine targets for 2019-nCoV." F1000Research 9 (2020).
2. Grifoni, Alba, et al. "A sequence homology and
bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2." Cell host & microbe
(2020).
3. Cheung, Y. K., et al. "Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid
protein and their role in the prevention and treatment of SARS infection." Hong Kong medical journal= Xianggang yi
xue za zhi 14 (2008): 27-30.
4. Wan Y, Shang J, et al. Receptor recognition by the novel coronavirus from
Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020 Mar 17;94(7).
5.
Chen Y, et al. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020 Feb
17.
6. Vickers, C. et al. J. Biol. Chem. 277, 14838 (2002).
7. Huang, L. et al. J. Biol. Chem. 278,
15532 (2003).
